LAPTM5.md
... ...
@@ -12,8 +12,8 @@ Mutations in this gene were first described in DLBCL and FL in 2021 by Hübschma
12 12
13 13
|Entity|Tier|Description |
14 14
|:------:|:----:|-----------------------------------------|
15
-|![DLBCL](images/icons/DLBCL_tier2.png) |2-a | aSHM target; Although recurrent, the relevance of mutations in DLBCL is tenuous |
16
-|![FL](images/icons/FL_tier2.png) |2-a | aSHM target; Although recurrent, the relevance of mutations in FL is tenuous [@hubschmannMutationalMechanismsShaping2021]|
15
+|![DLBCL](images/icons/DLBCL_tier2.png) |2 | aSHM target; Although recurrent, the relevance of mutations in DLBCL is tenuous |
16
+|![FL](images/icons/FL_tier2.png) |2 | aSHM target; Although recurrent, the relevance of mutations in FL is tenuous [@hubschmannMutationalMechanismsShaping2021]|
17 17
18 18
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
19 19